Singapore Cloud Computing Platforms for Life Sciences Market
完整報告名稱與涵蓋範圍
Singapore Cloud Computing Platforms for Life Sciences Market Size, Share & Trends Analysis Report, By Platform Type (Hyperscale Cloud Infrastructure and AI Compute Services, Life Sciences SaaS Platforms (Clinical, Regulatory, Quality and Commercial), Scientific Data, Genomics and Research Cloud Platforms, Managed Services, Integration and Sovereign Cloud Offerings), By Application (Research and Drug Discovery, Clinical Trials and Regulatory Operations, Biomanufacturing and Quality Systems, Healthcare Data, Diagnostics and Digital Health), By End User (Pharmaceutical and Biotechnology Companies, Biomanufacturing and CDMO Sites, Research Institutes, Hospitals and Government Agencies), and Segment Forecasts, 2026-2035
報告摘要
The Singapore cloud computing platforms for life sciences market covers hyperscale cloud infrastructure and AI compute, life sciences software-as-a-service platforms for clinical, regulatory, quality and commercial functions, scientific data and genomics research clouds and managed, integration and sovereign cloud services consumed by pharmaceutical and biotechnology companies, biomanufacturing sites, research institutes and healthcare organisations in Singapore. Cloud spending outside Singapore and general enterprise cloud use by non-life-science organisations are excluded.
Singapore hosts regional headquarters and manufacturing sites for many global pharmaceutical and medical technology companies, a concentrated public research ecosystem and national genomics and health data programs, all of which are migrating workloads to cloud platforms for research collaboration, regulated operations and AI. Demand is driven by biomanufacturing digitalisation and quality systems, by regional clinical trial coordination hubs, by national precision medicine programs that generate large genomic datasets and by government incentives for digital and AI adoption. Data residency and health data governance rules, the availability of hyperscale regions and sovereign offerings within the country, validated cloud services for regulated processes and skilled talent shape platform selection.
Within Singapore, demand concentrates in the biomedical manufacturing clusters, research campuses and hospital and health technology agencies. Competition involves hyperscalers with local regions, life sciences software specialists, local telecom and IT service providers and system integrators.
The InsightAce study supplies US$ forecasts for all platform type, application and end user segments over 2026-2035, segment-level trend analysis, competitive landscape assessment and profiling of the leading companies.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Singapore Cloud Computing Platforms for Life Sciences Market Snapshot
Chapter 4. Singapore Cloud Computing Platforms for Life Sciences Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Platform Type Estimates & Trend Analysis
5.1. Platform Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Platform Type:
5.2.1. Hyperscale Cloud Infrastructure and AI Compute Services
5.2.2. Life Sciences SaaS Platforms (Clinical, Regulatory, Quality and Commercial)
5.2.3. Scientific Data, Genomics and Research Cloud Platforms
5.2.4. Managed Services, Integration and Sovereign Cloud Offerings
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. Application & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
6.2.1. Research and Drug Discovery
6.2.2. Clinical Trials and Regulatory Operations
6.2.3. Biomanufacturing and Quality Systems
6.2.4. Healthcare Data, Diagnostics and Digital Health
Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. End User & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
7.2.1. Pharmaceutical and Biotechnology Companies
7.2.2. Biomanufacturing and CDMO Sites
7.2.3. Research Institutes, Hospitals and Government Agencies
Chapter 8. Singapore Cloud Computing Platforms for Life Sciences Market: Country Outlook & Operating Environment
8.1. Regulatory & Policy Framework
8.2. Pricing, Reimbursement & Procurement Environment
8.3. Demand Outlook & Adoption Trends, 2026-2035
Chapter 9. Competitive Landscape
9.1. Company Market Positioning Analysis
9.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 10. Company Profiles
10.1. Amazon Web Services, Inc.
10.2. Microsoft Corporation (Azure)
10.3. Google Cloud
10.4. Oracle Corporation (Oracle Cloud Infrastructure)
10.5. IBM Corporation
10.6. Alibaba Cloud
10.7. Veeva Systems Inc.
10.8. Benchling, Inc.
10.9. Medidata (Dassault Systemes SE)
10.10. NCS Group (Singtel)
10.11. ST Engineering (Cloud and Data)
10.12. Singapore Telecommunications Limited
10.13. Accenture plc (Singapore)
10.14. Illumina, Inc. (Singapore Operations)
10.15. A*STAR (Adjacent Research Infrastructure)
圖表清單 List of Tables & Figures
Table 1. Singapore Cloud Computing Platforms for Life Sciences Market Revenue Forecast by Platform Type, 2026-2035 (US$ Mn)
Figure 1. Singapore Cloud Computing Platforms for Life Sciences Market Segmentation and Scope Overview
Table 2. Singapore Cloud Computing Platforms for Life Sciences Market Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 2. Singapore Cloud Computing Platforms for Life Sciences Market Share by Platform Type, 2026 & 2035
Table 3. Singapore Cloud Computing Platforms for Life Sciences Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 3. Singapore Life Sciences Cloud Demand by Platform Type and Application, 2026-2035
Table 4. Singapore Cloud Computing Platforms for Life Sciences Market Revenue and Volume Snapshot, 2026-2035
Figure 4. Data Residency, Health Data Governance and Sovereign Cloud Requirements in Singapore
Table 5. Strategic Developments of Leading Singapore Cloud Computing Platforms for Life Sciences Market Participants, 2023-2026
Figure 5. Singapore Cloud Computing Platforms for Life Sciences Market Growth Opportunity Analysis by Segment, 2026-2035
Figure 6. Competitive Positioning of Key Singapore Cloud Computing Platforms for Life Sciences Market Participants
Figure 7. Porter's Five Forces Analysis of the Singapore Cloud Computing Platforms for Life Sciences Market
Figure 8. Life Sciences Ecosystem in Singapore and Its Cloud Workload Migration Drivers
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們